Edwards Lifesciences Corp. (EW)
84.24
+0.32
(+0.38%)
USD |
NYSE |
Dec 11, 16:00
84.23
-0.01
(-0.01%)
After-Hours: 20:00
Edwards Lifesciences Cash from Investing (Quarterly): -661.50M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| Abbott Laboratories | -457.00M |
| Stryker Corp. | -321.00M |
| Zimmer Biomet Holdings, Inc. | -163.30M |
| Pulse Biosciences, Inc. | -0.062M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 573.70M |
| Cash from Financing (Quarterly) | -506.40M |
| Free Cash Flow | 799.60M |
| Free Cash Flow Per Share (Quarterly) | 0.8813 |
| Free Cash Flow to Equity (Quarterly) | 518.50M |
| Free Cash Flow to Firm (Quarterly) | 516.20M |
| Free Cash Flow Yield | 1.61% |